These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9613139)

  • 1. [Telomerase activity in association with the pathological differentiation of prostate cancer].
    Uemura H; Lin Y; Kubota Y
    Nihon Rinsho; 1998 May; 56(5):1287-91. PubMed ID: 9613139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity in primary prostate cancer.
    Lin Y; Uemura H; Fujinami K; Hosaka M; Harada M; Kubota Y
    J Urol; 1997 Mar; 157(3):1161-5. PubMed ID: 9072562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of telomerase activity in prostate needle-biopsy samples].
    Wang X; Zhang Y; Ding Q; Ye L; Zhai L; Jia W
    Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):762-4. PubMed ID: 11829949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of telomerase activity in prostate cancer by needle biopsy.
    Takahashi C; Miyagawa I; Kumano S; Oshimura M
    Eur Urol; 1997; 32(4):494-8. PubMed ID: 9412813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage.
    Meid FH; Gygi CM; Leisinger HJ; Bosman FT; Benhattar J
    J Urol; 2001 May; 165(5):1802-5. PubMed ID: 11342979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of telomerase activity in prostate needle-biopsy samples.
    Lin Y; Uemura H; Fujinami K; Hosaka M; Iwasaki Y; Kitamura H; Harada M; Kubota Y
    Prostate; 1998 Jul; 36(2):121-8. PubMed ID: 9655264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity.
    Botchkina GI; Kim RH; Botchkina IL; Kirshenbaum A; Frischer Z; Adler HL
    Clin Cancer Res; 2005 May; 11(9):3243-9. PubMed ID: 15867219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal intratumoral heterogeneity for telomerase activity in human prostate cancer.
    Wullich B; Rohde V; Oehlenschläger B; Bonkhoff H; Ketter R; Zwergel T; Sattler HP
    J Urol; 1999 Jun; 161(6):1997-2001. PubMed ID: 10332489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity: comparison between fine-needle aspiration and biopsy specimens for the detection of tumor cells.
    Naritoku WY; Datar RH; Li P; Groshen SL; Taylor CR; Imam SA
    Cancer; 1999 Aug; 87(4):210-5. PubMed ID: 10455209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer.
    Suh CI; Shanafelt T; May DJ; Shroyer KR; Bobak JB; Crawford ED; Miller GJ; Markham N; Glode LM
    Mol Cell Probes; 2000 Aug; 14(4):211-7. PubMed ID: 10970725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity in needle biopsies from prostate cancer and benign prostates.
    Wymenga LF; Wisman GB; Veenstra R; Ruiters MH; Mensink HJ
    Eur J Clin Invest; 2000 Apr; 30(4):330-5. PubMed ID: 10759882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer].
    He GP; Shui QL; Huang Y; Zhang SZ; Yu H
    Ai Zheng; 2004 Sep; 23(9):1041-6. PubMed ID: 15363198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
    Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H
    Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of in situ TRAP assay detecting telomerase activity in cell].
    Ohyashiki K; Yahata N; Ohyashiki JH
    Nihon Rinsho; 1998 May; 56(5):1159-64. PubMed ID: 9613114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
    Fujita M; Tomita S; Fukui H; Ueda Y; Fujimori T
    J Exp Clin Cancer Res; 1999 Mar; 18(1):119-24. PubMed ID: 10374691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.
    Zhang W; Kapusta LR; Slingerland JM; Klotz LH
    Cancer Res; 1998 Feb; 58(4):619-21. PubMed ID: 9485010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity: a prevalent marker of malignant human prostate tissue.
    Sommerfeld HJ; Meeker AK; Piatyszek MA; Bova GS; Shay JW; Coffey DS
    Cancer Res; 1996 Jan; 56(1):218-22. PubMed ID: 8548767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results.
    Crocitto LE; Korns D; Kretzner L; Shevchuk T; Blair SL; Wilson TG; Ramin SA; Kawachi MH; Smith SS
    Urology; 2004 Oct; 64(4):821-5. PubMed ID: 15491741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay.
    Takaishi H; Kitamoto M; Takahashi S; Aikata H; Kawakami Y; Nakanishi T; Nakamura Y; Shimamoto F; Kajiyama G; Ide T
    Cancer; 2000 Jan; 88(2):312-7. PubMed ID: 10640962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.